Shari Collins
About Shari Collins
Shari Collins serves as the Vice President of Product Commercialization and Marketing at Sanguine, having previously held various marketing and commercialization roles in the biotechnology sector, including positions at Agilent Technologies and IsoPlexis.
Current Role at Sanguine
Shari Collins serves as the Vice President of Product Commercialization and Marketing at Sanguine, a position she has held since 2024. In this role, she is responsible for overseeing product commercialization strategies and marketing initiatives. Her focus includes maximizing product line growth and enhancing brand awareness within the organization.
Previous Experience at Agilent Technologies
Prior to her current role, Collins worked at Agilent Technologies from 2018 to 2022. She held several positions, including Global Commercialization Manager in the Cell Analysis Division and Director of Product Marketing. During her tenure, she contributed to portfolio optimization and managed the entire product lifecycle from commercialization to obsolescence.
Experience at IsoPlexis
Collins worked at IsoPlexis as Vice President of Marketing from 2022 to 2023 and previously as Sr. Director of Marketing in 2022. Her responsibilities included portfolio development, product messaging, and pipeline generation, focusing on human biospecimen services and products.
Educational Background
Shari Collins studied at Boston University, where she earned a degree in Biochemistry and Molecular Biology from 1993 to 1997. This educational foundation has supported her career in product commercialization and marketing within the biotechnology sector.
Early Career and Research Experience
Collins began her career as a Clinical Research Assistant at Baylor Research Institute from 1999 to 2000. She also worked as a Graduate Student Researcher at the University of California, Santa Cruz in 1998. These early roles provided her with valuable experience in research and clinical settings.